Erythromycin 2% Topical Solution is an anti acne vulgaris solution with bacteriostatic action against propionibacterium acnes.

Packaging: 60ml PE Bottle with applicator

Erythromycin 2 w/w.




Solution for topical use.






4.1 Therapeutic indications


Stiemycin is indicated for use in the treatment of acne vulgaris.


4.2 Posology and method of administration


To be applied to the affected area twice daily after washing with soap and water.


4.3 Contraindications


Stiemycin is contraindicated in patients with known sensitivity to any of the ingredients.


4.4 Special warnings and precautions for use


Avoid contact with eyes and other mucous membranes. Concomitant topical acne therapy should be used with caution because a cumulative irritant effect may occur.


4.5 Interaction with other medicinal products and other forms of interaction


None known.


4.6 Pregnancy and lactation


There is no evidence of hazard from erythromycin in human pregnancy. It has been in wide use for many years without apparent ill consequence.


4.7 Effects on ability to drive and use machines




4.8 Undesirable effects




4.9 Overdose


Not applicable.






5.1 Pharmacodynamic properties


Erythromycin suppresses Propionibacterium acnes, a resident bacterial of sebaceous follicles, and as a result of this organism's role in the hydrolysis of triglycerides to free fatty acids, administration decreases fatty acid formation. This is thought to be responsible for its effectiveness in reducing acne lesion counts and the fatty acid to fatty ester ratios in acne patients.


5.2 Pharmacokinetic properties


Not applicable.